South Australia is set to trial a digitalised colonoscopy database led by Flinders University for managing the rising demand for colonoscopies.

The trial will also help create a data registry for cancer research in the future.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Surveillance for Colorectal Cancer Prevention (SCOPE) project will focus on developing, validating and implementing a digital intervention surveillance to optimise bowel cancer detection.

SCOPE will also use artificial intelligence for lowering bowel cancer risk in Australia.

Five different hospital networks in South Australia will implement the project for determining the programme’s suitability, feasibility and cost-effectiveness.

The Australian Government Medical Research Future Fund National Critical Research Infrastructure Grant has provided A$2.9m ($1.9m) for the project.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Associate Professor Erin Symonds from the College of Medicine and Public Health and Flinders Medical Centre will lead the project as a chief investigator.

Symonds said: “The trial will build on the success of our proven framework for surveillance of those at increased risk for bowel cancer and provide a digital solution that links and collates data from existing hospital records and uses artificial intelligence algorithms to determine the appropriate surveillance recommendations based on current guidelines.”

Endorsed by national and international cancer prevention agencies, the new project also includes other researchers from Flinders University, University of Adelaide, Commission on Excellence and Innovation in Health and Cancer Council NSW.

This project is based on the success of the Southern Co-operative Program for the Prevention of Colorectal Cancer, which was launched in 1999 at Flinders Medical Centre.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact